secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001213900-23-052454
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics implements 1-for-40 reverse stock split to meet Nasdaq minimum bid requirement
--------------------------------------------------------------------------------

- Reverse stock split effective 4:05 pm NY time June 28, 2023 at a 1-for-40 ratio.
- Outstanding shares reduced from 20,142,633 to approximately 503,566; fractional shares rounded up.
- Split intended to increase per-share price and bring company into compliance with Nasdaq minimum bid price.
- Common stock begins trading on post-split basis under symbol ALLR on June 29, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023052454/0001213900-23-052454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023052454/ea180985-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-052454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer